Cara Therapeutics, Inc. (NASDAQ:CARA) Short Interest Up 15.2% in November

Cara Therapeutics, Inc. (NASDAQ:CARA – Get Free Report) was the recipient of a significant growth in short interest in the month of November. As of November 15th, there was short interest totalling 3,420,000 shares, a growth of 15.2% from the October 31st total of 2,970,000 shares. Currently, 7.4% of the company’s shares are sold short. […]

Related Keywords

United States ,Piper Sandler ,Stifel Nicolaus ,Jag Capital Management ,Needham Company ,Nasdaq ,Cetera Advisor Networks ,Sigma Securities ,Hermes Inc ,Tower Research Capital ,Cara Therapeutics Inc ,Cara Therapeutics ,Get Free Report ,Research Capital ,Advisor Networks ,Capital Management ,Two Sigma Securities ,Cara Therapeutics Daily ,Nasdaq Cara ,Cara ,Medical ,Stocks ,Options ,Put ,Call ,